Navigation Links
FDA to Broaden Disclosure on Advisers' Conflicts of Interest
Date:4/21/2010

Agency has faced criticism in the past over the issue

WEDNESDAY, April 21 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday proposed new guidelines to help give the public more information on the experts the agency places on its all-important advisory committees, which help approve drugs and devices.

The FDA has in the past been criticized for allowing individuals with conflict of interests to serve on these panels. In some cases, prospective committee members with financial or other ties to a product under discussion can still receive special conflict-of-interest waivers that allow their participation on an advisory panel.

But on Wednesday the agency proposed new guidelines that, in its words, would "expand transparency and [public] disclosure" whenever one of these waivers are handed out.

FDA advisory committees provide the agency with advice on a wide range of topics, including drugs, medical devices and tobacco. They also provide key advice on regulatory decisions, such as product approvals and general policy matters. While the FDA is not bound to follow its committees' recommendations, it usually does.

"The primary goal of the advisory committee process is to bring high-quality input to FDA to inform our decision making," Jill Hartzler Warner, the FDA's acting associate commissioner for special medical programs, explained during a press conference Wednesday.

The new guidelines would expand the information disclosed to the public whenever the FDA grants a conflict-of-interest waiver, Warner said.

The FDA has 49 advisory committees with room for more than 600 members. Currently, there are over 200 vacancies on these committees, according to the agency.

Under the proposed guidelines, the FDA would disclose conflict-of-interest waivers before committee meetings, naming the company or institution and any financial interest advisers might have as well as the specific conflict of interest.

"In my view, it is clearly better for the agency in fulfilling its public health mission when advisers have no conflicts of interest," FDA Commissioner Dr. Margaret A. Hamburg wrote in a letter to senior agency officials. "FDA staff should search far and wide for experts who have the requisite knowledge without conflicts of interest. At the same time, however, I recognize the fact that many of the top authorities in specific areas may have conflicts of interest."

In the letter, Hamburg outlined three steps to consider before a conflict-of-interest waiver is given. These include:

  • Defining the nature of the conflict of interest before recommending giving a waiver. "Not all conflicts are created equal. For example, an academic researcher whose institution receives grants from an affected company but who does not personally participate in the studies has a more tangential relationship to the conflict than the researcher who conducts studies for the company directly," she wrote.
  • Weighing the kind of advice the committee is being asked for. "A waiver may be more appropriate for a meeting about a policy issue affecting a class of entities or products than for a meeting focusing on approval of a specific product," Hamburg explained.
  • Determining why expert advisers without conflicts could not be found and why the individual under scrutiny is needed.

"Conflict-of-interest waivers for scientific advisers have been controversial, however," Hamburg wrote. "If FDA is perceived to rely heavily on conflicted experts, then confidence in the agency's decision-making can be undermined."

More information

For more on the proposed guidelines, visit the U.S. Food and Drug Administration.



SOURCES: April 21, 2010, teleconference with Jill Hartzler Warner, J.D., acting associate commissioner for special medical programs, U.S. Food and Drug Administration; April 21, 2010, letter, Margaret A. Hamburg, M.D., commissioner, U.S. Food and Drug Administration


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Healthy Aging Global Leader Broadens Patient Exercise/Nutrition Success With Online Living Site
2. SOKO Fitness & Spa Group Broadens Geographic Expansion Strategy
3. Pivot Networks and Brookside Technology Partners, Inc. Team to Broaden Managed IT Services Offering for Texas SMBs
4. BD Applauds PEPFARs Broadened Emphasis on Strengthening Health Systems
5. Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research
6. Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective
7. FDA Advisers Urge Stricter Regulation of Tanning Beds
8. Primary care physicians nationwide face clinical ethical conflicts with religious hospitals
9. Couples who say we do better at resolving conflicts
10. NursePractitionerBusinessOwner.com Announces No-Charge Teleseminar for Nurse Practitioners Interested in Starting Their Own Practice
11. Study shows strong interest in palliative care programs, services and integration vary across nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... New studies published today ... workers across 15 states. The outcomes examined in these studies include recovery of ... and satisfaction with medical care. , “The goal of the studies is to ...
(Date:5/25/2016)... ... May 25, 2016 , ... Cheryl Bowker of Bowker Insurance Group has ... McKenna Good Hands Legacy Award. McKenna ran one of Allstate’s most successful agencies for ... all those who knew him. The award named for him is not given every ...
(Date:5/25/2016)... ... May 25, 2016 , ... Casa Velas, an adults-only ... of precious stones to complement its new wellness suites . The two 1,350 ... feature a plethora of special services and insuite amenities, from a custom soap selection ...
(Date:5/25/2016)... PALM BEACH COUNTY, FLA (PRWEB) , ... May 25, 2016 , ... ... Florida the latest technology to help turn back the hands of time of female ... with female aging and childbirth. Women with symptoms such as leakage, laxity, itchiness ...
(Date:5/25/2016)... ... May 25, 2016 , ... First Choice Emergency Room , the largest ... Nguyen, as the Medical Director of its new DeSoto facility. , “We are ... DeSoto location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... NEW YORK , May 23, 2016 /PRNewswire/ ... Mass Spectrometry Market Size, Share, Development, Growth and ... Platform (Hybrid, Single and Other), by Application (Drug ... Others), by End Users (Pharmaceuticals, Life Science and ... Published by P&S Market Research, the global ...
(Date:5/23/2016)... DHABI , UAE, May 23, 2016 ... the importance of Precision Medicine and the role ...     The First International Conference ... under the distinguished patronage and presence of Sheikh Nahyan ... The conference focused in Precision Medicine, which helps provide personalized ...
(Date:5/22/2016)... , May 23, 2016 ... develop its anti-fibrotic and anti-inflammatory compound DS102 in ... as in non-alcoholic steatohepatitis (NASH) patients. ... significantly sequestered in lung tissue and has bronchodilatory, ... after oral administration. The Company will publish further ...
Breaking Medicine Technology: